Cargando…
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments
Rosacea is a common, chronic inflammatory skin disease that can present with a variety of signs and symptoms. The potentially simultaneous occurrence of different signs and symptoms is due to different underlying inflammatory pathways, emphasizing the need for complementary treatment approaches. Top...
Autores principales: | Steinhoff, Martin, Vocanson, Marc, Voegel, Johannes J, Hacini-Rachinel, Feriel, Schäfer, Gregor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020118/ https://www.ncbi.nlm.nih.gov/pubmed/27432381 http://dx.doi.org/10.1007/s12325-016-0380-z |
Ejemplares similares
-
Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily
por: Del Rosso, James Q., et al.
Publicado: (2021) -
Safety and efficacy of doxycycline in the treatment of rosacea
por: Valentín, Sheila, et al.
Publicado: (2009) -
Oral Probiotic Control Skin Inflammation by Acting on Both Effector and Regulatory T Cells
por: Hacini-Rachinel, Feriel, et al.
Publicado: (2009) -
Beneficial effect of hydrolyzed egg in allergy
por: Nutten, Sophie, et al.
Publicado: (2011) -
Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations
por: Ebbelaar, Chiel Cristiano F., et al.
Publicado: (2018)